An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus

Condition:   Systemic Lupus Erythematosus (SLE) Intervention:   Drug: anti-CD19 CAR NK cells (KN5501) Sponsors:   Changhai Hospital;   Nanjing Enricnk Biotech Co., Ltd Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials